BrightSpring Health Services just delivered the kind of quarter that forces short term traders to look up from their screens. The stock jumped 11.1% in regular trading after its Q3 2026 report, extending an already stron
Why BTSG Stock advanced +1.28% Today — RQD Quant Desk Flash
BrightSpring Health Services Inc. (BTSG) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Why BTSG Stock advanced +1.28% Today — RQD Quant Desk Flash
BrightSpring Health Services Inc. (BTSG) advanced +1.28% to $60.22 as options desks priced 54% call premium vs. 46% put protection around the $59 max-pain magnet. Solid 12% profit margin (6% return on capital), mixed timing at 63x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 69% of its 52-week range ($30.64 – $73.75) with RSI-14 at 67.3 (BULLISH MOMENTUM).
- ▸Whale Options Positioning: $2.4M in bullish call flow vs. $2.1M in put flow (Put/Call 0.84x, implied earnings swing ±6.7%).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 11.8% gross margin and $394.7M annual free cash flow.
BrightSpring Health Services (BTSG) moved into focus after third quarter 2026 results came in ahead of analyst expectations and management raised full year revenue and adjusted EBITDA guidance, signalling stronger operat
Shares of healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) jumped 9.2% in the afternoon session after the company reported third-quarter 2026 financial results and raised its full-year 2026 guidanc
BrightSpring Health Services has seen its share price climb sharply over the past year, which puts a spotlight on whether the current valuation is still in line with what its earnings can support. With investors reacting
Moby summary of BrightSpring Health Services, Inc. Common Stock's Q3 2026 earnings call
BrightSpring Health Services (NASDAQ:BTSG) reported third-quarter results above its forecast, with revenue rising 26% year over year to $4.2 billion and adjusted EBITDA increasing 42% to $228 million. Adjusted earnings p
Key TakeawaysBrightSpring Health Services stock jumped 12% as adjusted EBITDA rose 42% and 2026 guidance went up. Gross profit per script rose 27% in what management calls the peak year for Medicare’s drug-price negotiat
2026-10-30. The following slide deck was published by BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. (BTSG) Q3 2026 Earnings Call October 30, 2026 8:30 AM EDTCompany ParticipantsDavid Deuchler - Senior VP of Strategic...
Specialty pharmacy script volume surged 29% as home health integration accelerates.
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live BTSG Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
BTSG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +28.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BTSG today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BTSG. Explore sector supply chains on /butterfly.
BTSG Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is BTSG stock moving today?
Why BTSG Stock advanced +1.28% Today — RQD Quant Desk Flash. Solid 12% profit margin (6% return on capital), mixed timing at 63x P/E—hold if owned, no rush to chase.